HIGHLIGHTS
- who: Zachary M. Harris et al. from the Section of Pulmonary, Critical Care, and Sleep MedicineSection of Pulmonary, Critical Care, and Sleep Medicine have published the research work: Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury, in the Journal: Oxidative Medicine and Cellular Longevity of 20/09/2022
- what: This study investigated the role of epidermal growth factor receptor (EGFR) in hyperoxia-induced lung injury at very high oxygen levels (>95%). This analysis showed high EGFR expression in epithelial and endothelial cells , which has been shown previously in lung epithelial and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.